The Living Guidelines: UA/NSTEMI Recommendations for Initial Conservative vs. Initial Invasive Strategies Polling Results for CLASS IIb Guidelines

Any recommendations found on these pages are for education use only. WikiDoc is not a substitute for a licensed healthcare provider. Please see the disclaimers page for important information regarding limitations of the information found here. In suggesting edits to the guidelines, WikiDoc suggests that the following classification scheme be used. Read more about the classification scheme used by the ACC / AHA Guidelines Committee here.

Class IIb Guidelines
1a. In initially stabilized patients, an initially conservative (i.e., a selectively invasive) strategy may be considered as a treatment strategy for UA/NSTEMI patients (without serious comorbidities or contraindications to such procedures) who have an elevated risk for clinical events including those who are troponin positive. (Class IIb Level of Evidence: B)

 UA/NSTEMI Guidelines Class IIb Recommendation 1a for Additional Management Considerations for Antiplatelet and Anticoagulant Therapy should be: CLASS I CLASS IIa CLASS IIb CLASS III

1b. The decision to implement an initial conservative (vs. initial invasive) strategy in these patients may be made by considering physician and patient preference. (Level of Evidence: C)

 UA/NSTEMI Guidelines Class IIb Recommendation 1b for Additional Management Considerations for Antiplatelet and Anticoagulant Therapy should be: CLASS I CLASS IIa CLASS IIb CLASS III

2. An invasive strategy may be reasonable in patients with chronic renal insufficiency. (Level of Evidence: C)

 UA/NSTEMI Guidelines Class IIb Recommendation 2 for Additional Management Considerations for Antiplatelet and Anticoagulant Therapy should be: CLASS I CLASS IIa CLASS IIb CLASS III